0001493152-23-024684.txt : 20230717 0001493152-23-024684.hdr.sgml : 20230717 20230717121036 ACCESSION NUMBER: 0001493152-23-024684 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230717 DATE AS OF CHANGE: 20230717 EFFECTIVENESS DATE: 20230717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sonnet BioTherapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001106838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522102141 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-487073 FILM NUMBER: 231091000 BUSINESS ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-375-2227 MAIL ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: Chanticleer Holdings, Inc. DATE OF NAME CHANGE: 20050510 FORMER COMPANY: FORMER CONFORMED NAME: TULVINE SYSTEMS INC DATE OF NAME CHANGE: 20000214 D 1 primary_doc.xml X0708 D LIVE 0001106838 Sonnet BioTherapeutics Holdings, Inc. 100 OVERLOOK CETNER SUITE 102 PRINCETON NJ NEW JERSEY 08540 609-375-2227 DELAWARE Tulvine Systems Inc Chanticleer Holdings, Inc. TULVINE SYSTEMS INC Corporation true Pankaj Mohan 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Executive Officer Director Jay Cross 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Executive Officer John K. Cini 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Executive Officer Susan Dexter 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Executive Officer Richard Kenny 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Executive Officer Nailesh Bhatt 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Director Albert Dyrness 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Director Donald Griffith 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Director Raghu Rao 100 Overlook Center Suite 102 Princeton NJ NEW JERSEY 08540 Director Biotechnology Decline to Disclose 06b false 2023-06-30 false true true true false 0 Chardan Capital Markets, LLC 120128 None None 17 STATE STREET SUITE 2130 NEW YORK NY NEW YORK 10004 All States false 2250000 2250000 0 false 1 226250 0 0 true The Company shall use the net proceeds from the sale for working capital purposes. false Sonnet BioTherapeutics Holdings, Inc. /s/ Jay Cross Jay Cross Chief Financial Officer 2023-07-17